Connor, Clark & Lunn Investment Management (CC&L)
MRK icon

Connor, Clark & Lunn Investment Management (CC&L)’s Merck MRK Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.5M Buy
203,676
+120,466
+145% +$13.9M 0.06% 277
2025
Q4 		$8.76M Buy
83,210
+76,607
+1,160% +$7.19M 0.02% 495
2025
Q3 		$554K Hold
6,603
– – ﹤0.01% 1231
2025
Q2 		$523K Sell
6,603
-4,920
-43% -$391K ﹤0.01% 1240
2025
Q1 		$1.03M Sell
11,523
-291,231
-96% -$27.2M ﹤0.01% 936
2024
Q4 		$30.1M Sell
302,754
-213,090
-41% -$22M 0.14% 120
2024
Q3 		$58.6M Sell
515,844
-792,148
-61% -$94.1M 0.28% 60
2024
Q2 		$162M Buy
1,307,992
+1,003,550
+330% +$129M 0.68% 33
2024
Q1 		$40.2M Sell
304,442
-981,782
-76% -$121M 0.17% 113
2023
Q4 		$140M Buy
1,286,224
+675,787
+111% +$70.1M 0.65% 38
2023
Q3 		$62.8M Buy
610,437
+402,110
+193% +$43.3M 0.33% 62
2023
Q2 		$24M Sell
208,327
-15,503
-7% -$1.76M 0.12% 135
2023
Q1 		$23.8M Sell
223,830
-61,318
-22% -$6.62M 0.13% 134
2022
Q4 		$31.6M Sell
285,148
-16,308
-5% -$1.67M 0.18% 97
2022
Q3 		$26M Sell
301,456
-374,260
-55% -$33.4M 0.17% 96
2022
Q2 		$61.6M Sell
675,716
-246,196
-27% -$21.8M 0.37% 45
2022
Q1 		$75.6M Sell
921,912
-281,884
-23% -$22.2M 0.37% 49
2021
Q4 		$92.3M Buy
1,203,796
+77,005
+7% +$6.13M 0.45% 51
2021
Q3 		$84.6M Buy
1,126,791
+766,591
+213% +$58.3M 0.44% 48
2021
Q2 		$28M Sell
360,200
-601,529
-63% -$44.7M 0.14% 133
2021
Q1 		$70.7M Buy
961,729
+19,249
+2% +$1.42M 0.39% 49
2020
Q4 		$73.6M Buy
942,480
+259,259
+38% +$19.8M 0.43% 53
2020
Q3 		$54.1M Buy
683,221
+206,941
+43% +$16.2M 0.36% 61
2020
Q2 		$35.1M Sell
476,280
-298,728
-39% -$22.5M 0.25% 79
2020
Q1 		$56.9M Buy
775,008
+273,607
+55% +$21.5M 0.51% 39
2019
Q4 		$43.5M Buy
501,401
+139,579
+39% +$11.5M 0.3% 71
2019
Q3 		$29.1M Buy
361,822
+151,305
+72% +$12.1M 0.2% 99
2019
Q2 		$16.8M Buy
210,517
+38,435
+22% +$2.94M 0.11% 140
2019
Q1 		$13.7M Buy
+172,082
New +$12.9M 0.09% 158
2018
Q4 		– Sell
-197,848
Closed -$13.4M – 1007
2018
Q3 		$13.4M Sell
197,848
-335,491
-63% -$21.4M 0.08% 179
2018
Q2 		$30.9M Sell
533,339
-470,578
-47% -$26.5M 0.17% 92
2018
Q1 		$52.2M Sell
1,003,917
-4,585
-0.5% -$248K 0.32% 66
2017
Q4 		$54.1M Buy
1,008,502
+95,342
+10% +$5.29M 0.32% 63
2017
Q3 		$55.8M Buy
913,160
+562,656
+161% +$34.1M 0.33% 57
2017
Q2 		$21.4M Buy
350,504
+253,040
+260% +$15.4M 0.14% 108
2017
Q1 		$5.91M Buy
+97,464
New +$5.91M 0.04% 224
2016
Q4 		– Sell
-322,049
Closed -$19.2M – 950
2016
Q3 		$19.2M Sell
322,049
-316,863
-50% -$18.5M 0.13% 119
2016
Q2 		$35.1M Sell
638,912
-126,310
-17% -$6.72M 0.26% 72
2016
Q1 		$38.6M Sell
765,222
-14,306
-2% -$701K 0.3% 55
2015
Q4 		$39.3M Sell
779,528
-126,729
-14% -$6.39M 0.33% 52
2015
Q3 		$42.7M Buy
906,257
+411,104
+83% +$21.8M 0.35% 52
2015
Q2 		$26.9M Buy
495,153
+152,956
+45% +$8.58M 0.24% 67
2015
Q1 		$18.8M Sell
342,197
-23,790
-7% -$1.35M 0.16% 77
2014
Q4 		$19.8M Sell
365,987
-204,360
-36% -$11.4M 0.16% 74
2014
Q3 		$32.3M Sell
570,347
-12,052
-2% -$677K 0.26% 52
2014
Q2 		$34.2M Buy
582,399
+360,198
+162% +$19.6M 0.24% 63
2014
Q1 		$13.3M Sell
222,201
-107,839
-33% -$5.58M 0.1% 97
2013
Q4 		$16.7M Buy
330,040
+146,074
+79% +$6.68M 0.13% 75
2013
Q3 		$8.59M Sell
183,966
-30,916
-14% -$1.41M 0.08% 81
2013
Q2 		$10M Buy
+214,882
New +$9.6M 0.1% 80

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s MRK Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) increased its Merck (MRK) stake by 145% in Q1 2026, buying an estimated $13.9M and bringing the position to 203,676 shares worth $24.5M. The position accounts for 0.06% of the portfolio, ranked #277.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in MRK in Q2 2013 and has held it in 50 quarters since. The position peaked at $162M in Q2 2024. 3,789 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 203,676 shares of Merck worth $24.5M as of Q1 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) bought 120,466 Merck shares in Q1 2026, an estimated $13.9M.
  • Merck made up 0.06% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #277 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Merck in Q2 2013 and has held it in 50 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Merck position peaked at $162M in Q2 2024.
  • 3,789 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.